129 related articles for article (PubMed ID: 2639694)
1. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Lee SS; Lee TS; Park JS; Cho EK; Chung CH
J Korean Med Sci; 1989 Dec; 4(4):193-201. PubMed ID: 2639694
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Risio M; Coverlizza S; Poccardi G; Candelaresi GL; Gaiola O
Basic Appl Histochem; 1986; 30(4):469-77. PubMed ID: 3548696
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Yoshinouchi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2513-21. PubMed ID: 2614188
[TBL] [Abstract][Full Text] [Related]
5. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
Kanno M; Takeda Y; Nakamura S
Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Miller MA; Mazewski CM; Yousuf N; Sheikh Y; White LM; Yanik GA; Hyams DM; Lampkin BC; Raza A
J Histochem Cytochem; 1991 Apr; 39(4):407-12. PubMed ID: 2005370
[TBL] [Abstract][Full Text] [Related]
7. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
8. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
9. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.
Magaud JP; Sargent I; Clarke PJ; Ffrench M; Rimokh R; Mason DY
J Histochem Cytochem; 1989 Oct; 37(10):1517-27. PubMed ID: 2476478
[TBL] [Abstract][Full Text] [Related]
10. [Postnatal cell proliferation in the rat cerebrum: immunohistochemical study with bromodeoxyuridine (BrdU)].
Fujita T; Yoshimine T; Hayakawa T; Ushio Y; Takemoto O; Maruno M; Kano M; Mogami H
No To Shinkei; 1988 Jul; 40(7):651-5. PubMed ID: 3066383
[TBL] [Abstract][Full Text] [Related]
11. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling.
Meyer JS; Nauert J; Koehm S; Hughes J
J Histochem Cytochem; 1989 Sep; 37(9):1449-54. PubMed ID: 2768814
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M
J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726
[TBL] [Abstract][Full Text] [Related]
14. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
Veronese S; Gambacorta M; Falini B
J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528
[TBL] [Abstract][Full Text] [Related]
15. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
Meyer JS; Koehm SL; Hughes JM; Higa E; Wittliff JL; Lagos JA; Manes JL
Cancer; 1993 Jun; 71(11):3531-40. PubMed ID: 8490901
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical detection of S-phase cells in gynecologic malignancies using anti-BrdU monoclonal antibody.
Fukuda K; Iwasaka T; Hachisuga T; Hayashi Y; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):493-4. PubMed ID: 3373078
[No Abstract] [Full Text] [Related]
17. A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling.
Yoshida K; Morinaga S; Shimosato Y; Hayata Y
Cancer; 1989 Dec; 64(11):2284-91. PubMed ID: 2553243
[TBL] [Abstract][Full Text] [Related]
18. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Gunduz N
Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration with anti-bromodeoxyuridine monoclonal antibody in experimental meningeal carcinomatosis model.
Huang TY; Hwang SL; Howng SL
Kaohsiung J Med Sci; 1997 Mar; 13(3):136-40. PubMed ID: 9109299
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
